Fernanda Torres
Research Subjects
Fernanda Torres has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Antonella Tosti
University of Miami Miller School of Medicine
2 shared publications A Tosti
1 shared publication- Andrea Sechi
Dermatology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy
1 shared publication - Angelo Valerio Marzano
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy
1 shared publication - Antonella Tosti
Fredric Brandt Endowed Professor of Dermatology, Miller School of Medicine, University of Miami, Miami, FL 33146, USA
1 shared publication - Bianca Maria Piraccini
Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine University of Bologna Bologna Italy
1 shared publication
Latest Publications
- Open Access
Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
Among the distressing side effects of cancer treatments, hair loss is one of the most disturbing for the quality of life and adherence to therapy in breast cancer patients. Many patients take nutritional supplements to prevent hair loss or enhance regrowth. Based on their mechanism and timing of use, nutritional supplements could be divided into safe, cautious, debated, and contraindicated categories. Non-contraindicated supplements generally include safe supplements like vitamin D, which is not known to interfere with cancer treatments. Those that are contraindicated include phytoestrogens and compounds affecting estrogen pathways because of the risk of stimulating tumor growth in cancers sensitive to estrogen. Antioxidants like tocotrienols and resveratrol are given judiciously because of potential interference with cancer therapies dependent on reactive oxygen species. Supplements debated, including nicotinamide, folate, and iron, pose a risk by promoting cellular proliferation or altering the tumor microenvironment. Biotin is nontoxic but interferes with blood test results and is thus difficult in cancer monitoring. Evidence regarding nutritional supplements’ safety and efficacy in this context is conflicting. Management by an oncologist is required along with more studies to clearly establish the safety parameters and efficacy guidelines.
Open AccessSafety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
Among the distressing side effects of cancer treatments, hair loss is one of the most disturbing for the quality of life and adherence to therapy in breast cancer patients. Many patients take nutritional supplements to prevent hair loss or enhance regrowth. Based on their mechanism and timing of use, nutritional supplements could be divided into safe, cautious, debated, and contraindicated categories. Non-contraindicated supplements generally include safe supplements like vitamin D, which is not known to interfere with cancer treatments. Those that are contraindicated include phytoestrogens and compounds affecting estrogen pathways because of the risk of stimulating tumor growth in cancers sensitive to estrogen. Antioxidants like tocotrienols and resveratrol are given judiciously because of potential interference with cancer therapies dependent on reactive oxygen species. Supplements debated, including nicotinamide, folate, and iron, pose a risk by promoting cellular proliferation or altering the tumor microenvironment. Biotin is nontoxic but interferes with blood test results and is thus difficult in cancer monitoring. Evidence regarding nutritional supplements’ safety and efficacy in this context is conflicting. Management by an oncologist is required along with more studies to clearly establish the safety parameters and efficacy guidelines.
- 1 June 2015
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 34 (2) , 67-71
Female pattern alopecia and telogen effuvium: figuring out diffuse alopecia
One of the major challenges when evaluating diffuse hair loss in women is to determine the cause of the hair loss.
- 1 June 2015
- Published by Frontline Medical Communications, Inc. in Seminars in Cutaneous Medicine and Surgery
- Vol. 34 (2) , 67-71
Female pattern alopecia and telogen effuvium: figuring out diffuse alopecia
One of the major challenges when evaluating diffuse hair loss in women is to determine the cause of the hair loss.
- 20 February 2015
- Published by S. Karger AG
- Vol. 47, 33-44
Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
Male baldness is the most common diagnosis in men that present with hair loss. It is a genetically determined condition that is clearly an androgen-dependent trait, mainly driven by dihydrotestosterone action on the hair follicles, leading to miniaturization. Although in general this condition is socially accepted as a natural process in a man's life, for some individuals it might significantly impact quality of life, reducing self-esteem and increasing stress. This chapter encompasses the most important aspects of the practical evaluation (clinical features, trichoscopy, trichogram, histopathology, relevant blood tests) and management of male baldness, diffuse baldness and senescent alopecia.
- 20 February 2015
- Published by S. Karger AG
- Vol. 47, 33-44
Androgenetic, Diffuse and Senescent Alopecia in Men: Practical Evaluation and Management
Male baldness is the most common diagnosis in men that present with hair loss. It is a genetically determined condition that is clearly an androgen-dependent trait, mainly driven by dihydrotestosterone action on the hair follicles, leading to miniaturization. Although in general this condition is socially accepted as a natural process in a man's life, for some individuals it might significantly impact quality of life, reducing self-esteem and increasing stress. This chapter encompasses the most important aspects of the practical evaluation (clinical features, trichoscopy, trichogram, histopathology, relevant blood tests) and management of male baldness, diffuse baldness and senescent alopecia.
- 1 February 2014
- Vol. 149 (1) , 83-91
Trichoscopy: an update.
Hair and scalp disorders represent a substantial complaint in most dermatologists' daily practice. Trichoscopy is a simple and easy-to-perform technique that has been utilized for diagnosis and management of these patients. The interest for this technique had increased in the last years, and knowledge had expanded. This article reviews the most important dermoscopic patterns in normal Caucasian and African scalp, as well as in the most common trichological conditions.
- 1 February 2014
- Vol. 149 (1) , 83-91
Trichoscopy: an update.
Hair and scalp disorders represent a substantial complaint in most dermatologists' daily practice. Trichoscopy is a simple and easy-to-perform technique that has been utilized for diagnosis and management of these patients. The interest for this technique had increased in the last years, and knowledge had expanded. This article reviews the most important dermoscopic patterns in normal Caucasian and African scalp, as well as in the most common trichological conditions.
- 26 April 2011
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 164 (5) , 1122-1124
Reflectance confocal microscopy can differentiate dermoscopic white dots of the scalp between sweat gland ducts or follicular infundibulum
- 26 April 2011
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 164 (5) , 1122-1124
Reflectance confocal microscopy can differentiate dermoscopic white dots of the scalp between sweat gland ducts or follicular infundibulum
- 23 February 2011
- Published by Wiley in International Journal of Dermatology
- Vol. 50 (3) , 358-361
Trichoscopy as a clue to the diagnosis of scalp sarcoidosis
Background Sarcoidosis is an idiopathic systemic granulomatous disease, in which non‐caseating granulomas formations can occur in any organ. Although rare, involvement of the scalp can occur, which might lead to cicatricial alopecia. Dermoscopic features of scalp sarcoidosis had not been reported.Methods Clinical, dermoscopic, and histopathological features of two patients with scalp sarcoidosis were reviewed.Results Two Caucasian female patients aged 22 and 60 years old presented with diffuse folliculitis‐like lesions and patchy alopecia, respectively. Dermoscopy of the lesions showed decreased hair density associated with perifollicular and follicular yellowish to pale orange round spots in the first case and diffuse orange discoloration with prominent telangiectasia in the second patient. Few dystrophic hairs were seen in both cases.Conclusions The orange spots seen at trichoscopy of lesions in scalp sarcoidosis may represent a clue to the diagnosis of this condition. Dystrophic hairs may indicate granulomatous activity.
- 23 February 2011
- Published by Wiley in International Journal of Dermatology
- Vol. 50 (3) , 358-361
Trichoscopy as a clue to the diagnosis of scalp sarcoidosis
Background Sarcoidosis is an idiopathic systemic granulomatous disease, in which non‐caseating granulomas formations can occur in any organ. Although rare, involvement of the scalp can occur, which might lead to cicatricial alopecia. Dermoscopic features of scalp sarcoidosis had not been reported.Methods Clinical, dermoscopic, and histopathological features of two patients with scalp sarcoidosis were reviewed.Results Two Caucasian female patients aged 22 and 60 years old presented with diffuse folliculitis‐like lesions and patchy alopecia, respectively. Dermoscopy of the lesions showed decreased hair density associated with perifollicular and follicular yellowish to pale orange round spots in the first case and diffuse orange discoloration with prominent telangiectasia in the second patient. Few dystrophic hairs were seen in both cases.Conclusions The orange spots seen at trichoscopy of lesions in scalp sarcoidosis may represent a clue to the diagnosis of this condition. Dystrophic hairs may indicate granulomatous activity.